Current role
Household & Personal Products · Consumer Defensive
COO, Board Member
2021-01-01–present
Tom Myers
Board Member
Pure Bioscience, Inc. (PURE)Equibles does not estimate personal net worth.
Get an email with a short summary when Pure Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get PURE alertsAbout Tom Myers
Tom Myers is recorded as Board Member at Pure Bioscience, Inc. (PURE) since January 1, 2021 and COO at Pure Bioscience, Inc. (PURE). The newest filing on record that lists Tom Myers as Board Member at Pure Bioscience, Inc. (PURE) is dated December 30, 2025. The newest filing on record that lists Tom Myers as COO at Pure Bioscience, Inc. (PURE) is dated December 23, 2022. Pure Bioscience, Inc. reported in an 8-K filed March 21, 2023 that Tom Myers resigned as Chief Operating Officer, effective March 15, 2023. The proxy statement of Pure Bioscience, Inc. reports total compensation of $197,400 for Tom Myers in fiscal 2025, including a base salary of $188,000. Disclosed compensation is on record for 5 fiscal years. Pure Bioscience, Inc. is classified in the Household & Personal Products industry within the Consumer Defensive sector. Other leadership on record at Pure Bioscience, Inc. includes Robert Bartlett (CEO and Board Member), Bernard Blotner (Board Member), Darin Zehr (Board Member) and 3 others.
“Tom Myers, the Company's Chief Operating Officer and member of the Board, resigned as the Company's Chief Operating Officer in connection with his transition to the Company's Executive Vice President, Technology and Development, each effective as of the Effective Date.”
Affiliation history
-
Current
2021-01-01–present
Last confirmed December 30, 2025
-
Current
Start not stated–present
Last confirmed December 23, 2022
-
Pure Bioscience, Inc. (PURE)
Proxy statement
Start not stated–2024-12-12
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Pure Bioscience, Inc.
- Robert Bartlett CEO, Board Member
- Bernard Blotner Board Member
- Darin Zehr Board Member
- David M. Rendall Board Member
- Ivan Chen Board Member
- Tom Y. Lee Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pure Bioscience, Inc. (PURE) | Executive Vice President of Technology & Development | $188,000 | $197,400 |
| 2024 | Pure Bioscience, Inc. (PURE) | Executive Vice President of Technology & Development | $200,000 | $215,000 |
| 2023 | Pure Bioscience, Inc. (PURE) | Executive Vice President of Technology & Development | $200,000 | $237,000 |
| 2022 | Pure Bioscience, Inc. (PURE) | Executive Vice President of Technology & Development | $200,000 | $200,000 |
| 2021 | Pure Bioscience, Inc. (PURE) | Chief Operating Officer | $200,000 | $231,000 |